Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer

doi:10.1158/1078-0432.CCR-18-1894

Review

. 2019 Aug 15;25(16):4881-4887.

doi: 10.1158/1078-0432.CCR-18-1894. Epub 2019 Mar 25.

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer

David F Heigener^{1

2

3}, Keith M Kerr⁴, Gavin M Laing⁴, Tony S K Mok⁵, Fedor V Moiseyenko^{6

7}, Martin Reck^{3

8

9}

Affiliations

¹ Department of Pulmonology, Helios Klinikum Schleswig, Schleswig, Germany. dheigener@aol.com.
² Christian-Albrechts-University, Kiel, Germany.
³ Airway Research Center North in the German Center for Lung Research (DZL), Grosshansdorf, Germany.
⁴ Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, Scotland.
⁵ Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
⁶ Institute of Oncology NN Petrov-Saint Petersburg, Pesochny, Russia.
⁷ St. Petersburg City Cancer Center, St. Petersburg, Russia.
⁸ LungenClinic Grosshansdorf, Grosshansdorf, Germany.
⁹ University of Lübeck, Lübeck,Germany.

PMID: 30910855
DOI: 10.1158/1078-0432.CCR-18-1894

Review

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer

David F Heigener et al. Clin Cancer Res. 2019.

. 2019 Aug 15;25(16):4881-4887.

doi: 10.1158/1078-0432.CCR-18-1894. Epub 2019 Mar 25.

Authors

David F Heigener^{1

2

3}, Keith M Kerr⁴, Gavin M Laing⁴, Tony S K Mok⁵, Fedor V Moiseyenko^{6

7}, Martin Reck^{3

8

9}

Affiliations

¹ Department of Pulmonology, Helios Klinikum Schleswig, Schleswig, Germany. dheigener@aol.com.
² Christian-Albrechts-University, Kiel, Germany.
³ Airway Research Center North in the German Center for Lung Research (DZL), Grosshansdorf, Germany.
⁴ Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, Scotland.
⁵ Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
⁶ Institute of Oncology NN Petrov-Saint Petersburg, Pesochny, Russia.
⁷ St. Petersburg City Cancer Center, St. Petersburg, Russia.
⁸ LungenClinic Grosshansdorf, Grosshansdorf, Germany.
⁹ University of Lübeck, Lübeck,Germany.

PMID: 30910855
DOI: 10.1158/1078-0432.CCR-18-1894

Abstract

Metastatic non-small-cell lung cancer is still a devastating disease; however, treatment options have diversified dramatically in the past two decades. From unselected platinum-based chemotherapy for all patients, several different treatment groups have evolved, that is, those with "druggable" targets, those with a promising immune signature, and those without any predicting factors outlined in this article. Challenge includes the intersections between these groups and the optimal treatment path. These issues will be addressed in this review.

PubMed Disclaimer

Cited by

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay.
Belloum Y, Janning M, Mohme M, Simon R, Kropidlowski J, Sartori A, Irwin D, Westphal M, Lamszus K, Loges S, Riethdorf S, Pantel K, Wikman H. Belloum Y, et al. Cells. 2020 Oct 22;9(11):2337. doi: 10.3390/cells9112337. Cells. 2020. PMID: 33105541 Free PMC article.
Inetetamab, a novel anti-HER2 monoclonal antibody, exhibits potent synergistic anticancer effects with cisplatin by inducing pyroptosis in lung adenocarcinoma.
Cui J, He Y, Zhu F, Gong W, Zuo R, Wang Y, Luo Y, Chen L, Wang C, Huo G, Lu H, Liu Z, Chen P, Guo H. Cui J, et al. Int J Biol Sci. 2023 Aug 6;19(13):4061-4081. doi: 10.7150/ijbs.82980. eCollection 2023. Int J Biol Sci. 2023. PMID: 37705753 Free PMC article.
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Prelaj A, Pircher CC, Massa G, Martelli V, Corrao G, Lo Russo G, Proto C, Ferrara R, Galli G, De Toma A, Genova C, Jereczek-Fossa BA, Braud F, Garassino MC, Rebuzzi SE. Prelaj A, et al. Cancers (Basel). 2021 Mar 15;13(6):1300. doi: 10.3390/cancers13061300. Cancers (Basel). 2021. PMID: 33803958 Free PMC article. Review.
Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer.
Nian R, Jiang H, Zhao J, Hou W, Zhang H, Ma J, Lv P, Jiang L, Wang Y, Xu Y, Wu S, Lou J, Li W. Nian R, et al. Int J Oncol. 2022 Sep;61(3):100. doi: 10.3892/ijo.2022.5390. Epub 2022 Jul 7. Int J Oncol. 2022. PMID: 35796015 Free PMC article.
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC.
Aya F, Benegas M, Viñolas N, Reyes R, Vollmer I, Arcocha A, Sánchez M, Reguart N. Aya F, et al. Cancers (Basel). 2021 Nov 6;13(21):5566. doi: 10.3390/cancers13215566. Cancers (Basel). 2021. PMID: 34771728 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer

Affiliations

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous